Ibtel-AM 80mg/5mg Tablet
By Ibtel-AM
Rx
10 Tablet in a Strip
Composition
Telmisartan(80mg) + Amlodipine(5mg)
Manufacturer - Indiabulls pharmaceutical ltd
Indiabulls Pharmaceuticals Limited is M – 62 & 63, First Floor, Connaught Place, New Delhi – 11000
Expires on or after
July, 2025
When using Ibtel-AM 80mg/5mg Tablet, it is important to exercise caution if you have liver disease. Your doctor may need to adjust the dosage accordingly, so consulting them is essential. For those with a history of liver diseases or conditions, extra care is advised when taking Teltas Trio 40/10/6.5 Tablet 15's. Your doctor may modify the dose based on your condition. It is advisable to refrain from using Teltas Trio 40/10/6.5 Tablet 15's in cases of severe liver disease. Remember to always seek guidance from your doctor to ensure safe and appropriate usage of these medications.
Ibtel-AM 80mg/5mg Tablet is safe for use in patients with kidney disease without the need for dose adjustment. If you have a history of kidney conditions, take Teltas Trio 40/10/6.5 Tablet with caution. Your doctor may adjust the dose as needed, but avoid it if you have severe kidney disease.
It is not safe to drink alcohol while taking Ibtel-AM 80mg/5mg Tablet due to potential adverse effects like low blood pressure, dizziness, fainting, light-headedness, or headaches.
Ibtel-AM 80mg/5mg Tablet may cause side effects like dizziness, headaches, nausea, or tiredness, impacting driving ability. Exercise caution while driving if you experience these symptoms. Similarly, Teltas Trio 40/10/6.5 Tablet 15's may also induce dizziness or tiredness, advising against driving in such cases.
Ibtel-AM 80mg/5mg Tablet is unsafe during pregnancy due to risks to the developing baby. It may be prescribed in life-threatening situations if benefits outweigh risks. Consult your doctor before using. Teltas Trio 40/10/6.5 Tablet 15's is not recommended for pregnant women as it may harm the unborn baby. Consult a doctor if pregnant.
Ibtel-AM 80mg/5mg Tablet is likely safe during breastfeeding. Limited evidence shows no significant risk to the baby. For Teltas Trio 40/10/6.5 Tablet 15's, it may harm the baby through breast milk; avoid it while breastfeeding and seek medical advice.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹174
Inclusive of all taxes
Content verified by
Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024